- Home
- SOPA vs SCNI Comparison
SOPA vs SCNI Comparison
Compare SOPA & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOPA
- SCNI
- Stock Information
- Founded
- SOPA 2018
- SCNI 2003
- Country
- SOPA Singapore
- SCNI Israel
- Employees
- SOPA N/A
- SCNI N/A
- Industry
- SOPA EDP Services
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SOPA Technology
- SCNI Health Care
- Exchange
- SOPA Nasdaq
- SCNI Nasdaq
- Market Cap
- SOPA 3.5M
- SCNI 3.5M
- IPO Year
- SOPA 2021
- SCNI N/A
- Fundamental
- Price
- SOPA $0.83
- SCNI $3.48
- Analyst Decision
- SOPA Buy
- SCNI
- Analyst Count
- SOPA 2
- SCNI 0
- Target Price
- SOPA $16.00
- SCNI N/A
- AVG Volume (30 Days)
- SOPA 29.9K
- SCNI 13.2K
- Earning Date
- SOPA 11-15-2024
- SCNI 11-22-2024
- Dividend Yield
- SOPA N/A
- SCNI N/A
- EPS Growth
- SOPA N/A
- SCNI N/A
- EPS
- SOPA N/A
- SCNI 8.20
- Revenue
- SOPA $6,906,240.00
- SCNI $452,000.00
- Revenue This Year
- SOPA $14.21
- SCNI N/A
- Revenue Next Year
- SOPA $98.91
- SCNI N/A
- P/E Ratio
- SOPA N/A
- SCNI $0.42
- Revenue Growth
- SOPA N/A
- SCNI N/A
- 52 Week Low
- SOPA $0.73
- SCNI $2.23
- 52 Week High
- SOPA $5.10
- SCNI $8.92
- Technical
- Relative Strength Index (RSI)
- SOPA 42.29
- SCNI 56.32
- Support Level
- SOPA $0.82
- SCNI $3.20
- Resistance Level
- SOPA $0.95
- SCNI $3.55
- Average True Range (ATR)
- SOPA 0.07
- SCNI 0.18
- MACD
- SOPA -0.01
- SCNI 0.03
- Stochastic Oscillator
- SOPA 35.91
- SCNI 51.72
About SOPA Society Pass Incorporated
Society Pass Inc is building an ecosystem of platforms and technology-enabled companies that synergistically work together to transform how consumers and merchants interact with one another in Southeast Asia and South Asia. Through the acquisition of companies and partnerships with visionary entrepreneurs, the company meets the growing demand for better services in sectors such as lifestyle, beauty, travel, and food and beverage. The company currently operates in Six reportable operating segments: Online Grocery and Food and grocery deliveries, Digital marketing, Online ticketing and reservation, Telecommunications Reseller, e-commerce, and Merchant Point of Sale (merchant POS). The company generates the majority of its revenue from the Digital marketing segment.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.